Effect on high-density lipoprotein cholesterol of maximum dose simvastatin and atorvastatin in patients with hypercholesterolemia: Results of the Comparative HDL Efficacy and Safety Study (CHESS)
- 30 November 2003
- journal article
- clinical trial
- Published by Elsevier in American Heart Journal
- Vol. 146 (5) , 862-869
- https://doi.org/10.1016/s0002-8703(03)00440-x
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Comparison of efficacy and safety of atorvastatin and simvastatin in patients with dyslipidemia with and without coronary heart diseaseThe American Journal of Cardiology, 2002
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- Relation of Gemfibrozil Treatment and Lipid Levels With Major Coronary EventsJAMA, 2001
- A Comparison of Simvastatin and Atorvastatin up to Maximal Recommended Doses in a Large Multicenter Randomized Clinical TrialCurrent Medical Research and Opinion, 2001
- Relation Between Baseline and On-Treatment Lipid Parameters and First Acute Major Coronary Events in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS)Circulation, 2000
- HDL-cholesterol and the Treatment of Coronary Heart Disease: Contrasting Effects of Atorvastatin and SimvastatinCurrent Medical Research and Opinion, 2000
- Gemfibrozil for the Secondary Prevention of Coronary Heart Disease in Men with Low Levels of High-Density Lipoprotein CholesterolNew England Journal of Medicine, 1999
- Effects of high doses of simvastatin and atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-IThe American Journal of Cardiology, 1999
- Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol LevelsJAMA, 1998
- Comparative Dose Efficacy Study of Atorvastatin Versus Simvastatin, Pravastatin, Lovastatin, and Fluvastatin in Patients With Hypercholesterolemia (The CURVES Study) fn1fn1This study was supported by Parke-Davis, Division of Warner Lambert Company, Morris Plains, New Jersey. Manuscript received August 20, 1997; revised manuscript received and accepted November 24, 1997.The American Journal of Cardiology, 1998